Biocon Secures OCRPS from Biocon Biosphere, Biocon Pharma in ₹315 Crore Deal

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Biocon acquires Biocon Biosphere, Pharma for ₹315 Cr; Q3 net profit rises to ₹143.8 Cr

Biocon./Reuters

C

CNBC TV18•04-03-2026, 01:06

Biocon acquires Biocon Biosphere, Pharma for ₹315 Cr; Q3 net profit rises to ₹143.8 Cr

•Biocon completed the acquisition of Optionally Convertible Redeemable Non-Cumulative Preference Shares (OCRPS) of its wholly owned subsidiaries, Biocon Biosphere and Biocon Pharma, for ₹315 crore.
•The company acquired 11.53 crore OCRPS of Biocon Biosphere for ₹115.34 crore and 20 crore OCRPS of Biocon Pharma for ₹200 crore.
•Biocon Biosphere manufactures APIs and generic formulations, while Biocon Pharma develops generics for global markets including the US and Europe.
•These related-party transactions, exempt under SEBI Listing Regulations, aim to support ongoing business requirements like working capital and capex.
•Biocon reported Q3 net profit of ₹143.8 crore, significantly up from ₹25.1 crore year-ago, despite an exceptional loss of ₹293.4 crore; revenue and EBITDA missed estimates.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Biopol Chemicals IPO News

Biopol Chemicals, PAN HR Solution IPOs See Strong Investor Interest on Final Day

With the third quarter earnings season drawing to a close, there will be a beeline of companies reporting their quarterly results in the upcoming week. A combination of Nifty 50 companies, F&O stocks, and new listings as well, will be part of the list for the week. Here's a look at some of the major earnings that you should have your eyes on:

Biocon Biologics Targets FY27 Growth with New Approvals, GLP-1 Pipeline

Fitch Upgrades Biocon Biologics Outlook to Positive, Affirms BB- Rating

Fitch Upgrades Biocon Biologics Outlook to Positive, Affirms BB- Rating

Gainers & Losers: लगातार दो कारोबारी दिनों की गिरावट के बाद मार्केट आज संभला। हफ्ते के पहले कारोबारी दिन आज सेंसेक्स (Sensex) 650.39 प्वाइंट्स यानी 0.79% के उछाल के साथ 83,277.15 और निफ्टी 50 (Nifty 50) 211.65 प्वाइंट्स यानी 0.83% की बढ़त के साथ 25,682.75 पर बंद हुआ है। अब इंडिविजुअल स्टॉक्स की बात करें तो कुछ शेयरों में अपनी खास कॉरपोरेट एक्टिविटीज के चलते आज तेज उठा-पटक रही। उनमें से कुछ के बारे में यहां बताया जा रहा है तेज हलचल की वजह के साथ। (सभी भाव बीएसई से लिए गए हैं।)

Gainers & Losers: EaseMyTrip, Natco Pharma Soar; Ola Electric, Blue Jet Healthcare Dip

Indoco Remedies Shares Soar 7% on USFDA Approval for Brivaracetam Oral Solution

Indoco Remedies Shares Soar 7% on USFDA Approval for Brivaracetam Oral Solution

Q3 Results impact on LIC, Kaynes Tech shares

LIC Soars 8% on Strong Q3 Results, Kaynes Tech Falls as Profit Misses Estimates